About The CJKHD
Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology, is an open access, peer-reviewed online journal that encourages high quality submissions focused on clinical, translational and health services delivery research in the field of chronic kidney disease, dialysis, kidney transplantation and organ donation.
Our mandate is to promote and advocate for kidney health as it impacts national and international communities.
Joanne
Bargman
Joanne Bargman MD, FRCPC
Editorial Board Member
Dr. Bargman is a staff nephrologist at the University Health Network and professor of medicine at the University of Toronto. She received her MD cum laude from the University of Toronto. She pursued nephrology training at Stanford University. Her research focused on renal physiology and micropuncture. Upon returning to Toronto, she was recruited to the Toronto Western Hospital where she trained in peritoneal dialysis under Dr. Dimitrios Oreopoulos. She has more than 900 invited lectures internationally, on subjects as diverse as peritoneal dialysis, glomerulonephritis, and management of lupus. She is director of Peritoneal Dialysis for the University Health Network in Toronto, past-president of the International Society of Peritoneal Dialysis, and co-director of the Combined Renal-Rheumatology Lupus Clinic for the University Health Network. She has won the “Silver Shovel”, given by the graduating medical class of the University of Toronto to the best lecturer in the undergraduate years. She has also won the University of Toronto Faculty of Medicine Postgraduate Teaching Award, given to the best teacher in the postgraduate program. In 2013 she was the recipient of both the Donald Seldin Award for excellence in nephrology at the National Kidney Foundation (US) and the award for teaching excellence from the Canadian Society of Nephrology. She was the 2015 recipient of the Lifetime Achievement Award at the Annual Dialysis Conference in New Orleans, and received the International Distinguished Medal at the Spring Clinical Meetings of the National Kidney Foundation in 2016. In 2018 she was the recipient of the Gabor Zellerman Award for Research and Excellence in Peritoneal Dialysis. In 2021 she was awarded the Robert G. Narins Lifetime Achievement Award from the American Society of Nephrology. She is deputy editor of the Journal of the American Society of Nephrology. Dr. Bargman is co-author of the chapter “Chronic Kidney Disease” in the 17th, 18th, 19th, 20th and 21st editions of Harrison’s Principles of Internal Medicine.
Marisa
Battistella
Marisa Battistella, Pharm D
Editorial Board Member
Dr. Battistella is a pharmacy clinician scientist specializing in chronic kidney disease (CKD)at the Toronto General Hospital Research Institute and an associate professor at the University of Toronto. Dr. Battistella completed her Doctor of Pharmacy at the Idaho State University and her clinical pharmacy residency at Sunnybrook Hospital. The objective of her research program focuses on translational studies that address unmet clinical needs across the entire spectrum of pharmacotherapy care in the CKD patient, from pre-prescribing (using genomics to guide the selection of drugs) to deprescribing (tapering, stopping, discontinuing or withdrawing drugs), with the goal of managing polypharmacy (use of multiple medications) and improving patient outcomes. Dr. Battistella’s expertise in nephrology, clinical teaching and collaboration with a wide spectrum of researchers – has allowed her to build a research program focused on translating pharmacogenomics and pharmacokinetic data to patient care that will improve the pharmacotherapy management of patients suffering from chronic kidney disease.
The Battistella research group conducts multidisciplinary research on a range of topics including genomics, pharmacokinetics and deprescribing. Using in vitro cell cultures, her team investigates drug metabolism in CKD patients compared to healthy individuals. The team also conducts pharmacokinetic studies to ensure appropriate prescribing of antibiotics in patients with CKD. Finally, this group also works on developing and validating algorithms that are accessible to both clinicians and patients in order to optimize medications in the CKD population.
Bethany
Foster
Bethany Foster, MD, MSc, FRCPC
Editorial Board Member
Dr. Foster is the director of the Division of Pediatric Nephrology at the Montreal Children’s Hospital, a clinical epidemiologist and a professor of pediatrics at McGill University. Dr. Foster obtained her medical degree at the University of Ottawa, and then completed her residency in pediatrics and a clinical nephrology fellowship at the Montreal Children’s Hospital (MCH). She then completed her MSc in clinical epidemiology at the University of Pennsylvania and a research fellowship at the Children’s Hospital of Philadelphia before returning to MCH.
A clinical epidemiologist with a primary research focus on the long-term outcomes of children and young adults with kidney transplants, Dr. Foster has played an important leadership role in promoting child health research, clinical practice and education, locally, nationally and internationally. Dr. Foster has been funded by CIHR and NIH to study immunosuppressive medication adherence and graft outcomes in adolescent and young adult kidney transplant recipients, whom she has identified to be at particularly high risk of graft loss. She has also highlighted important differences in renal allograft outcomes by recipient sex, the magnitude and direction of which vary by recipient age and by donor sex.
Kevin
Burns
Kevin D. Burns MD, CM, FRCPC
Editorial Board Member
Dr. Burns is a professor of medicine and past vice chair of research for the Department of Medicine of the Ottawa Hospital and University of Ottawa. He is a senior scientist and director of the Kidney Research Centre of the Ottawa Hospital Research Institute, University of Ottawa, and is cross-appointed to the Department of Cellular and Molecular Medicine. Dr. Burns received his BSc and MD degrees from McGill University. He completed internal medicine residency and clinical nephrology fellowship training at the University of Ottawa, undertook basic science research training at Vanderbilt University Medical Center, and returned to Ottawa in 1992 as a clinician scientist. Dr. Burns was University and Hospital Division head of nephrology from 1997-2005.
Dr. Burns’ research is focused on the function and regulation of the intrarenal renin-angiotensin system in diabetic nephropathy and hypertension, and the pathogenesis and treatment of acute kidney injury. His laboratory has been supported by funds from the Canadian Institutes of Health Research (CIHR), the Kidney Foundation of Canada (KFOC), and the Canada Foundation for Innovation/Ontario Innovation Trust.
Dr. Burns is past president of the Canadian Society of Nephrology (CSN), and founded and directed the KRESCENT Program from 2004-2018, a national kidney research training program launched by the CSN, the KFOC, and the CIHR. In 2010, Dr. Burns received the Medal for Research Excellence from the KFOC, in recognition of his contributions to kidney research in Canada. In 2022, he was recipient of the Dr. J. David Grimes Career Achievement Award from the Ottawa Hospital Research Institute.
Edward (Ted)
Clark
Edward (Ted) G. Clark, MD, MSc, FRCPC
Editorial Board Member
Dr. Clark is a staff nephrologist, associate professor and medical director of critical care nephrology at the Ottawa Hospital and University of Ottawa. He is also cross-appointed to the School of Epidemiology and Public Health and an associate scientist in the Clinical Epidemiology Program of the Ottawa Hospital Research Institute. His medical education has been at Queen's University (Kingston, ON) and McGill University (Montreal, QC) with a Masters in epidemiology from the University of Ottawa. He is dual-trained and certified in nephrology and critical care medicine with a clinical and academic focus on acute kidney injury and renal replacement therapy.
Sacha
De Serres
Sacha De Serres, MD, MSc, FRCPC
Editorial Board Member
Dr. De Serres is an associate professor of medicine at Laval University and clinician scientist Junior II FRQS scholar. Dr. De Serres received his MD from University of Montreal and FRCPC in internal medicine and nephrology following residency at Laval University. He then completed a 3-year research fellowship in transplant immunology at the Brigham and Women’s Hospital and received a Master of Epidemiology from Harvard School of Public Health.
At the national level, he has served as chair of the 2018 Canadian Society of Transplantation Scientific Committee, in charge of organizing the Canadian Transplant Summit. At the international level, he has been elected as executive member of American Society of Transplantation Transplant Diagnostic Committee for a 2-year term, from 2016 to 2018. He also served as a member of the AST Transplantation and Immunology Research Network Scientific Committee from 2015 to 2018.
His research program focuses on cell-based assays to identify over-immunosuppression and on the mechanisms of antibody-mediated rejection. Since 2011, he has received continuous funding from different agencies including Kidney Foundation of Canada, CIHR, CFI and FRQS. His lab is currently funded by a CIHR Project Scheme grant and he is co-investigator and collaborator on several multicenter projects, including the CIHR-funded TMCT-04 trial and the Genome Canada-funded Can PREVENT AMR study.
Joanne
Kappel
Joanne Kappel BSc, MD, FRCPC
Editorial Board Member
Dr. Kappel is a clinical professor of medicine in the Division of Nephrology, University of Saskatchewan. Dr. Kappel is currently the Saskatchewan physician lead for Kidney Health and the medical lead for the Chronic Kidney Disease Clinic/Community Kidney Health Program, Saskatoon, Saskatchewan Health Authority. She is the medical advisor for the Saskatchewan branch of the Kidney Foundation and one of the co-chairs of the CanSOLVE CKD Knowledge User/Knowledge Translation committee. Research interests include patient/caregiver and public education about kidney health and quality improvement particularly with patient reported outcomes and experience measures. Dr. Kappel was awarded the Howard Vincent Reconciliation award from the CanSOLVE CKD network in 2021.
Meena
Karsanji
Meena Karsanji
Editorial Board Member
Ms. Meena Karsanji is a renal dietician at Vancouver Coastal Health. Her expertise includes working with individuals and groups, provide nutrition counselling and self-management support to help clients address their health problems.
Bryce
Kiberd
Bryce Kiberd, MD, FRCPC
Editorial Board Member
Dr. Kiberd completed his medical degree at the University of Toronto, Internal Medicine Residency at Dalhousie University and nephrology fellowship at University of Toronto and Stanford University. He has over 160 publications in peer reviewed journals and was given the Excellence in Clinical Practice Award by the Canadian Society of Transplantation. His research interests include medical decision analysis and economic evaluations in chronic kidney disease and transplantation. He is currently the acting Multiorgan Transplant Program director and Kidney Transplant Program director for Atlantic Canada.
Joseph
Kim
Joseph Kim MD, MHS, PhD, MBA, FRCPC
Editorial Board Member
Dr. Kim is a staff nephrologist in the Division of Nephrology and director of the
Kidney Transplant Program at the Toronto General Hospital, University Health Network.
He is also an associate Professor in the Department of Medicine and the Institute of
Health Policy, Management and Evaluation at the University of Toronto. He is the vice
chair of the Medical Advisory Committee at the University Health Network, chair of the
Data System Working Group for the Organ Donation and Transplantation Collaborative
at Health Canada, past-president of the board of directors for the Canadian Society of
Transplantation, past-President of the Canadian Organ Replacement Register board of
directors, and former vice-chair of the Data Advisory Committee at the U.S. Organ
Procurement and Transplantation Network. Dr. Kim completed medical school, internal
medicine residency, chief medical residency, and fellowships in nephrology and kidney
transplantation at the University of Toronto. In 2008, he earned a PhD in epidemiology
and a Master of Health Science in biostatistics at the Johns Hopkins Bloomberg School
of Public Health. In 2020, he completed a Global Executive MBA for healthcare and the
life sciences at the Rotman School of Management, University of Toronto. Dr. Kim’s
research interests include access to and outcomes of kidney transplantation using
centre- and population-based cohorts and the optimal use of data to inform health
system improvement. His methodological interest focuses on methods for causal
inference from observational data.
Abhijat
Kitchlu
Abhijat Kitchlu, MD, FRCPC
Editorial Board Member
Dr. Kitchlu is a staff nephrologist and clinician scientist at the University Health Network (UHN), and an assistant professor at the University of Toronto. Dr. Kitchlu obtained his medical degree from the University of Western Ontario, and completed his internal medicine and nephrology training at the University of Toronto. His research interests include onconephrology and acute kidney injury.
Gregory
Knoll
Gregory Knoll, MD, MSc, FRCPC
Editorial Board Member
Dr. Knoll is chair of the Department of Medicine at the University of Ottawa and the Ottawa Hospital. He is a full professor and currently holds a uOttawa Distinguished Chair in clinical transplantation research and is a senior scientist with the Clinical Epidemiology Program of the Ottawa Hospital Research Institute. His research involves various methodologies, including systematic reviews, observational studies and randomized trials with specific interests in studying quality measurement in kidney transplantation, selecting transplant candidates, pre-transplant cardiac screening and management strategies for the complications of kidney transplantation. Dr. Knoll has served on dozens of committees, boards, and working groups focused on improving the care of patients with kidney failure and kidney transplantation. He is a past president of the Canadian Society of Transplantation and previous program lead with the Canadian National Transplant Research Program. Recently, he has been involved at the Provincial and National levels working to implement quality and performance measurement standards for solid organ transplantation. He was the co-chair of the international KDIGO guidelines on the Evaluation and Management of Candidates for Kidney Transplantation.
Paul
Komenda
Paul Komenda, MD, MHA, FRCPC
Editorial Board Member
Dr. Komenda is an associate professor of medicine in the Division of Nephrology at the University of Manitoba. He currently serves as medical director of the Home Hemodialysis Program and director of research at Seven Oaks General Hospital in Winnipeg. His research interests include chronic kidney disease and home dialysis utilization and focuses in the research disciplines of clinical epidemiology, health economics and process Improvement.
Dr. Komenda earned his medical degree at the University of Manitoba, then pursued his internal medicine residency at the University of Western Ontario, followed by a nephrology fellowship at the University of British Columbia (UBC). He went on to complete a Masters in Health Administration at the Sauder School of Business/UBC in addition to receiving the Executive Training For Research Application Fellowship from the Canadian Foundation for Healthcare Improvement. Dr. Komenda has served on the scientific advisory board of NxStage Medical, and currently serves as chief medical officer at Quanta Dialysis Technologies, bringing novel patient oriented home hemodialysis devices to market.
Robyn
Langham
Robyn Langham, MD, AM
Editorial Board Member
Dr. Langham is head of the School of Rural Health at Monash University, a nephrologist and medical researcher. A clinician researcher, she has worked on the area of fibrosis in human renal disease, translating basic research findings into drug development opportunities. Dr. Langham has had a distinguished career as a medical specialist, and is recognized nationally and internationally for her leadership capabilities, as Past-President of the Australia and New Zealand Society of Nephrology and also through roles with the Australian Medical Association, Kidney Health Australia and the International Society of Nephrology. Dr. Langahm is a member of the Order of Australia. She was honored on the Queen’s Birthday 2022 Honors List for her significant service to renal health research and tertiary medical education.
Dr. Langham has been an ISN member since 2005 and currently serves as co-chair of the World Kidney Day Joint Steering Committee. She is a member of the Advocacy Working Group, OSEA Regional Board, and i3C (International Consortium CKDu Collaborators) Network.
Sara
Mahdavi
Sara Mahdavi, PhD
Editorial Board Member
Dr. Sara Mahdavi is a Research Fellow and International Scholar at Harvard T.H. Chan School of Public Health. She is an adjunct professor in the Department of Nutritional Sciences and a clinician scientist and research instructor in the Department of Community and Family Medicine at the University of Toronto. She is a clinical scientist and a nephrology renal dietician (RD) with specialized training in Gene-Nutrition interaction in young adults as well as chronic disease populations. She also holds a clinical instructor and research appointment with the Department of Community and Family Medicine at the University of Toronto and serves as a scientific advisor on several government, non-for-profit and for profit organizations. Dr. Mahdavi received her doctorate from the Faculty of Medicine at the University of Toronto in the field of gene-environment interactions and cardiometabolic disease. She has been practicing clinical dietetics over the last decade at several Ontario hospitals as well as private practice. Dr. Mahdavi has been an invited speaker at several medical conferences and for government agencies. She has published over a dozen original peer-reviewed scientific articles in top medical journals, has been an invited reviewer for several clinical journals and has been serving on the editorial board of CJKHD since its inception in 2014. Dr. Mahdavi’s clinical research and practice have varied from predictors of early insulin sensitivity and dietary patterns, complex disease genomics including gene-environment interaction on cardiovascular and diabetes susceptibility, kidney disease and related bone-mineral disorders, proteomics and metabolomics in early disease detection, rare genetic disorders such as Fabry disease, and innovative dermatological interventions including treatment of calciphylaxis.
Louise
Moist
Louise Moist, MD, MSc, FRCPC
Editorial Board Member
Dr. Moist is a clinician researcher and professor of medicine, epidemiology and biostatistics at the University of Western Ontario, associate chair, Division of Nephrology and associate director of the Center for Quality Improvement and Patient Safety. After obtaining her medical degree at McMaster University, Dr. Moist completed her internal medicine and nephrology certification as well as a Masters in epidemiology and biostatistics at the University of Western Ontario.
Dr Moist is a certified Canadian physician executive, credentialing her significant role in healthcare leadership. Dr Moist is an active clinician, teacher and researcher. Her research focus is in vascular access, CKD progression and quality improvement. Dr Moist’s publications include over 200 peer reviewed papers and her recent research is in Implementation Science, integrating best evidence to best practice. Recent awards include the Canadian Society of Nephrology Distinguished Service Award (2020), MAC Chairs Award for outstanding contribution to quality improvement and patient safety (2018).
Sharon
Nessim
Sharon Nessim, MD, MSc, FRCPC
Editorial Board Member
Dr. Nessim is an associate professor at McGill University and a nephrologist in the Department of Medicine at the Jewish General Hospital. She is the recipient of the Marc Goldstein Clinician of the Year Award (2004) and the Jewish General Hospital Department of Medicine Teacher of the Year Award. Dr. Nessim research focuses on in peritoneal dialysis, and she served as chair of the ISPD Education Committee from 2014-2022.
Neesh
Pannu
Neesh Pannu, MD, MSc, FRCPC
Editorial Board Member
Dr. Pannu is a nephrologist and professor in the Department of Medicine at the University of Alberta. She received her medical training at the University of Alberta, Stanford University and completed her SM in epidemiology and biostatistics at Harvard University. Her research interests are primarily in the area of diagnosis, management, and outcomes of acute kidney injury. She is member of the Alberta Kidney Disease Network (AKDN) and the Interdisciplinary Chronic Disease Collaboration (ICDC). She also holds positions as co-scientific director of the Alberta Health Services Kidney Health section of the Medicine Strategic Clinical Network and as associate dean of research at the University of Alberta.
Neil
Powe
Neil R. Powe, MD, MPH, MBA, RCPL
Editorial Board Member
Dr. Powe is the Constance B. Wofsy Distinguished Professor and vice-chair of medicine at the University of California San Francisco and chief of medicine at the Priscilla Chan and Mark Zuckerberg San Francisco General Hospital. He serves as leader of the University of California San Francisco Medicine Service at the Priscilla Chan and Mark Zuckerberg San Francisco General Hospital. Dr. Powe earned his medical degree at Harvard Medical School and his Master’s in public health at Harvard School of Public Health. He completed residency, was a Robert Wood Johnson Clinical Scholar and completed his MBA at the University of Pennsylvania. Dr. Powe’s interests are in improving discovery, education, clinical practice and organizational effectiveness in medicine, enhancing scholarship and multidisciplinary collaboration, and developing future talent and leadership in the health professions. He has a particular interest in cultivating young scientists who are addressing major problems in science, health and health care delivery.
Dr. Powe’s primary intellectual pursuits involve kidney disease patient-oriented research, epidemiology, disparities, and outcomes and effectiveness research. His research unites medicine and public health with the goals of saving and improving quality of human lives. It involves the knowledge of fundamental discoveries in biology and clinical medicine to advance the health of patients and populations affected by kidney disease. Dr. Powe is the recipient of the Heroes and Hearts Award from the San Francisco General Hospital Foundation, the John Phillips Memorial Award for Outstanding Work in Clinical Medicine from the American College of Physicians, and the David M. Hume Memorial Award from the National Kidney Foundation. He is also a fellow of the Royal College of Physicians-London.
Steven
Soroka
Steven Soroka, MD, FRCPC
Editorial Board Member
Dr. Soroka is a professor of medicine, nephrologist and surveyor for Accreditation Canada. He is also chair of the Physician Advisory Committee for Accreditation Canada and co-lead of the Central Zone Renal Program, Nova Scotia Health Authority (NSHA). Dr. Soroka has served as medical advisor to the Nova Scotia Renal Program, medical director of nephrology clinical trials, physician lead of the Capital District Renal Program, VP of medicine for Capital Health, and executive medical director of the Central Zone, NSHA. Dr. Soroka obtained his medical degree and completed his internal medicine training at the University of Saskatchewan, followed by a nephrology fellowship at the University of Alberta. Dr. Soroka is the recipient of the Dr. William Grigor Award, which is given to a physician under the age of 50 who has made an outstanding contribution benefitting the health of Nova Scotians, as well as the Dalhousie University R. Wayne Putman Award for Outstanding Contributions to Community continuing medical education (CME).
Paul
Stevens
Paul Stevens, MBBS, FRCP
Editorial Board Member
Dr. Stevens is a consultant nephrologist, medical director and clinical director at Kent and Canterbury Hospital. He qualified in 1980 from The London Hospital Medical College. Dr. Stevens trained in kidney medicine in the Royal Air Force and at Charing Cross Hospital, London, was appointed as consultant nephrologist in 1990 and subsequently took up the post of Clinical director of renal medicine at the Kent and Canterbury Hospital in 1995. Dr. Stevens has served as chair, South Thames MSTC in Nephrology, chair, East Kent Hospitals NHS Trust Medical Staff Committee, and chair, DGH Nephrologists Society. He is an ex-officio member of the Renal Association Executive, a member of Kidney Alliance, a member of the College Specialty Committee for Renal Disease, member of the Royal College Physicians and the Royal College General Practitioners UK CKD guidelines group. Dr. Stevens served as clinical advisor to NICE for the anaemia management in chronic kidney disease and chronic kidney disease guidelines. He is a member of the Department of Health renal pathology advisory group, member of the Department of Health Renal Advisory Group and co-chair of the Kidney disease Improving Global Outcomes Chronic Kidney Disease Guideline. He is past-president of the British Renal Society. And in 2014 was awarded the International Distinguished Medal by the National Kidney Foundation for his work in developing the international classification of kidney disease and international guidance for evaluation and management of chronic kidney disease.
Rita
Suri
Rita Suri, MD, MSc, FRCPC
Editorial Board Member
Dr. Suri is a nephrologist, associate professor and director of the Division of Nephrology at McGill University. She is actively engaged in clinical practice, teaching, and research, and is nationally recognized for her leadership in research, network development, and teaching. Dr. Suri is a CIHR-funded clinical researcher and FRQS Junior 2 research scholar with > 70 publications and 5 book chapters. Her research interests are in clinical trials of dialysis, dialysis prescription, and adequacy of dialysis. She has served on multiple guidelines committees for the CSN, KDOQI, and KDIGO. She is also a scientific officer for the CIHR Randomized Controlled Trials panel and the Kidney Foundation Grants Committee, and a member of the CIHR Advisory Board for the Institute of Circulatory and Respiratory Health. Dr. Suri is an active member in the Canadian Society of Nephrology. She has served on the board of directors as member at large for Quebec, participated in several program planning initiatives and committees for the Society, including the World Congress of Nephrology local organizing committee, and has delivered many lectures at the CSN pre-course. Her other accomplishments include chair and founder of the Canadian Nephrology Trials Network.
Katrin
Uhlig
Katrin Uhlig, MD, MS
Editorial Board Member
Dr. Uhlig is a nephrologist and rheumatologist, and senior medical director, Rare Genetic Diseases (RGD), at Agios Pharmaceuticals. She provides medical-scientific leadership in the design and execution of clinical research and development programs. Dr. Uhlig received her medical degree from Aachen University, Germany. She completed an internal medicine residency at Georgetown Medical center, rheumatology fellowship at Munich University Hospital, a clinical and research fellowship in nephrology at Tufts Medical Center and a Masters of Clinical Research at the Sackler School of Graduate Biomedical Sciences, Tufts University, Boston.
For 10+ years, Dr. Uhlig worked as an academic nephrologist and physician scientist at Tufts Medical Center, where she remains affiliated as an adjunct associate professor at Tufts University School of Medicine, Boston. She has led guideline development and synthesized evidence in all major therapeutic areas in nephrology. In 2014, her contributions as a guideline methodologist were recognized with the Garabed Eknoyan award of the National Kidney Foundation. Dr. Uhlig is well published and has presented her work at local, national, and international meetings.
In 2003, Dr. Uhlig transitioned into industry where she developed her interest in drug development, first as an epidemiologist and a medical advisor at IQVIA (previously Quintiles), a global CRO, then as a senior medical director in Clinical Development at Keryx Biopharmaceuticals and now at Agios. She is a member of the board of directors of the Kidney Health Initiative (KHI) and a co-chair for the KHI workgroup on Overcoming Barriers to Drug Development in Children with Chronic Kidney Disease.
Ron
Wald
Ron Wald MDCM, MPH, FRCPC
Editorial Board Member
Dr. Wald is a nephrologist and professor of medicine at the University of Toronto. A native of Montreal, he completed his undergraduate and medical degrees at McGill University and continued his clinical training in internal medicine and nephrology at the University of Toronto. Following this, he completed his Masters in Public Health at Harvard University and a research fellowship at Tufts Medical Center in Boston. Since joining the St. Michael’s Hospital Division of Nephrology in 2006, Dr. Wald has been responsible for the hospital’s acute dialysis program. In addition to attending on the hospital’s nephrology consult and ward services, he provides longitudinal care for patients on chronic hemodialysis and has an active general nephrology practice.
Dr. Wald’s research areas are critical care nephrology and maintenance dialysis. He was co-principal investigator of the STARRT-AKI trial, a Canadian Institutes of Health Research-funded international trial on the timing of dialysis initiation in critically ill patients with acute kidney injury. He is also interested in fluid management in the setting of acute kidney injury and the long-term outcomes of patients who survive an episode of acute kidney injury. In the realm of maintenance dialysis, he is on the leadership team of the multinational PHOSPHATE trial that is evaluating whether intensive serum phosphate lowering lowers the risk of major adverse cardiovascular events, as compared to a liberalized serum phosphate control. As a founding member of the Kidney Dialysis and Transplantation Program of the Institute for Clinical Evaluative Sciences, Dr. Wald is also involved in several studies that are using province-wide administrative data to answer research questions in kidney disease.
Lori
Wazny
Lori Wazny, Pharm D
Editorial Board Member
Dr. Wazny is a clinical pharmacist at the Health Sciences Centre, Manitoba Renal Program and an associate professor at the University of Manitoba. After completing her Doctor of Pharmacy in Minneapolis, Dr. Wazny completed her renal pharmacy research fellowship in Richmond, Virginia. Dr. Wazny is a clinical mentor to renal pharmacists to address issues, create standardized approaches to care and develop policies.
Deborah
Zimmerman
Deborah Zimmerman MD, FRCPC
Editorial Board Member
Dr. Zimmerman is an associate professor of medicine in the Division of Nephrology at the Ottawa Hospital and University of Ottawa.
Dr. Zimmerman received her undergraduate university training, MD and internal medicine residency at the University of Calgary. After completing her clinical nephrology fellowship at the University of Toronto, she enrolled in the Masters program in clinical epidemiology which she completed in 2001.
She is the current director for clinical research at the Kidney Research Centre and past president of the Canadian Society of Nephrology. Dr. Zimmerman’s research interests focuses on morbidity and mortality associated with end stage kidney disease treated with dialysis.
